{{Rsnum
|rsid=265548
|Chromosome=19
|position=17791525
|Orientation=plus
|GMAF=0.4784
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.2 | 53.6 | 23.2
| HCB | 5.1 | 34.6 | 60.3
| JPT | 7.1 | 38.1 | 54.9
| YRI | 54.1 | 43.2 | 2.7
| ASW | 52.6 | 35.1 | 12.3
| CHB | 5.1 | 34.6 | 60.3
| CHD | 5.5 | 35.8 | 58.7
| GIH | 21.8 | 46.5 | 31.7
| LWK | 50.5 | 37.6 | 11.9
| MEX | 19.0 | 46.6 | 34.5
| MKK | 34.0 | 50.6 | 15.4
| TSI | 28.7 | 42.6 | 28.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23300138
  |Trait=Tumor biomarkers
  |Title=A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
  |RiskAllele=C
  |Pval=1E-13
  |OR=.07
  |ORtxt=[0.029-0.115] U/ml decrease
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}